Efficacy of Methotrexate versus Azathioprine and Their Steroid Sparing Role in the Treatment of Chronic Actinic Dermatitis: A Randomized Control Trial
Fortune Journal of Health Sciences · 2022
DOI: 10.26502/fjhs.047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fortune Journal of Health Sciences, 2022. Verfasst von Mohammad Majid Paracha und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Paracha, M. M., khan, A. Q., Sagheer, F., & Zahoor, H. (2022). Efficacy of Methotrexate versus Azathioprine and Their Steroid Sparing Role in the Treatment of Chronic Actinic Dermatitis: A Randomized Control Trial. Fortune Journal of Health Sciences. https://doi.org/10.26502/fjhs.047
Vancouver
Paracha MM, khan AQ, Sagheer F, Zahoor H. Efficacy of Methotrexate versus Azathioprine and Their Steroid Sparing Role in the Treatment of Chronic Actinic Dermatitis: A Randomized Control Trial. Fortune Journal of Health Sciences. 2022. doi:10.26502/fjhs.047
BibTeX
@article{Paracha2022,
author = {Paracha, Mohammad Majid and khan, Abdul Qayum and Sagheer, Farah and Zahoor, Hina},
title = {Efficacy of Methotrexate versus Azathioprine and Their Steroid Sparing Role in the Treatment of Chronic Actinic Dermatitis: A Randomized Control Trial},
journal = {Fortune Journal of Health Sciences},
year = {2022},
doi = {10.26502/fjhs.047}
}
EUVIMED